Literature DB >> 11236063

The functions of the amyloid precursor protein gene.

P K Panegyres1.   

Abstract

The amyloid precursor protein (APP) gene and its protein products have multiple functions in the central nervous system and fulfil criteria as neuractive peptides: presence, release and identity of action. There is increased understanding of the role of secretases (proteases) in the metabolism of APP and the production of its peptide fragments. The APP gene and its products have physiological roles in synaptic action, development of the brain, and in the response to stress and injury. These functions reveal the strategic importance of APP in the workings of the brain and point to its evolutionary significance.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11236063     DOI: 10.1515/revneuro.2001.12.1.1

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  8 in total

Review 1.  Hox genes and their candidate downstream targets in the developing central nervous system.

Authors:  Z N Akin; A J Nazarali
Journal:  Cell Mol Neurobiol       Date:  2005-06       Impact factor: 5.046

2.  Down-regulation of amyloid precursor protein by peptide nucleic acid in vivo.

Authors:  Mona Boules; Katrina Williams; Elisa Gollatz; Abdul Fauq; Elliott Richelson
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 3.444

3.  The non-peptidic δ-opioid receptor agonist Tan-67 mediates neuroprotection post-ischemically and is associated with altered amyloid precursor protein expression, maturation and processing in mice.

Authors:  Jia-Wei Min; Yanying Liu; David Wang; Fangfang Qiao; Hongmin Wang
Journal:  J Neurochem       Date:  2017-12-19       Impact factor: 5.372

4.  Gene expression profiling in the stress control brain region hypothalamic paraventricular nucleus reveals a novel gene network including amyloid beta precursor protein.

Authors:  Amalia Tsolakidou; Ludwig Czibere; Benno Pütz; Dietrich Trümbach; Markus Panhuysen; Jan M Deussing; Wolfgang Wurst; Inge Sillaber; Rainer Landgraf; Florian Holsboer; Theo Rein
Journal:  BMC Genomics       Date:  2010-10-08       Impact factor: 3.969

Review 5.  Pharmacotherapeutic targets in Alzheimer's disease.

Authors:  Yif'at Biran; Colin L Masters; Kevin J Barnham; Ashley I Bush; Paul A Adlard
Journal:  J Cell Mol Med       Date:  2008-11-18       Impact factor: 5.310

Review 6.  Abeta aggregation and possible implications in Alzheimer's disease pathogenesis.

Authors:  Prashant R Bharadwaj; Ashok K Dubey; Colin L Masters; Ralph N Martins; Ian G Macreadie
Journal:  J Cell Mol Med       Date:  2009-03       Impact factor: 5.310

7.  The Basic Biology of BACE1: A Key Therapeutic Target for Alzheimer's Disease.

Authors:  S L Cole; R Vassar
Journal:  Curr Genomics       Date:  2007-12       Impact factor: 2.236

8.  The Alzheimer's disease beta-secretase enzyme, BACE1.

Authors:  Sarah L Cole; Robert Vassar
Journal:  Mol Neurodegener       Date:  2007-11-15       Impact factor: 14.195

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.